Cargando…

Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report

BACKGROUND: Recognition of rocuronium-induced anaphylaxis is often challenging, owing to its diverse clinical manifestations. Regarding treatment, several reports have described the efficacy of sugammadex, while conflicting reports have also been published. CASE: A 71-year-old man was scheduled to u...

Descripción completa

Detalles Bibliográficos
Autores principales: Takise, Yoshiaki, Kato, Jungo, Suhara, Tomohiro, Yamada, Takashige, Funakoshi, Takeru, Takahashi, Hayato, Amagai, Masayuki, Morisaki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721765/
https://www.ncbi.nlm.nih.gov/pubmed/33289045
http://dx.doi.org/10.1186/s40981-020-00402-y
_version_ 1783620089838305280
author Takise, Yoshiaki
Kato, Jungo
Suhara, Tomohiro
Yamada, Takashige
Funakoshi, Takeru
Takahashi, Hayato
Amagai, Masayuki
Morisaki, Hiroshi
author_facet Takise, Yoshiaki
Kato, Jungo
Suhara, Tomohiro
Yamada, Takashige
Funakoshi, Takeru
Takahashi, Hayato
Amagai, Masayuki
Morisaki, Hiroshi
author_sort Takise, Yoshiaki
collection PubMed
description BACKGROUND: Recognition of rocuronium-induced anaphylaxis is often challenging, owing to its diverse clinical manifestations. Regarding treatment, several reports have described the efficacy of sugammadex, while conflicting reports have also been published. CASE: A 71-year-old man was scheduled to undergo split-thickness skin grafting surgery on his hip. During the induction of general anesthesia, the patient developed profound circulatory collapse without any cutaneous manifestations, which required 40 min of cardiopulmonary resuscitation. Later, the patient developed circulatory collapse again during the induction of anesthesia for tracheostomy surgery, which apparently coincided with the administration of rocuronium. Rocuronium-induced anaphylactic shock was suspected, and the administration of sugammadex resulted in swift recovery of hemodynamics. The basophil activation test revealed a positive reaction to rocuronium. CONCLUSION: The possibility of rocuronium-induced anaphylaxis should be considered when the circulatory collapse coincides with rocuronium administration, even though cutaneous manifestation is absent. Sugammadex can be a treatment option in such atypical cases.
format Online
Article
Text
id pubmed-7721765
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-77217652020-12-11 Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report Takise, Yoshiaki Kato, Jungo Suhara, Tomohiro Yamada, Takashige Funakoshi, Takeru Takahashi, Hayato Amagai, Masayuki Morisaki, Hiroshi JA Clin Rep Case Report BACKGROUND: Recognition of rocuronium-induced anaphylaxis is often challenging, owing to its diverse clinical manifestations. Regarding treatment, several reports have described the efficacy of sugammadex, while conflicting reports have also been published. CASE: A 71-year-old man was scheduled to undergo split-thickness skin grafting surgery on his hip. During the induction of general anesthesia, the patient developed profound circulatory collapse without any cutaneous manifestations, which required 40 min of cardiopulmonary resuscitation. Later, the patient developed circulatory collapse again during the induction of anesthesia for tracheostomy surgery, which apparently coincided with the administration of rocuronium. Rocuronium-induced anaphylactic shock was suspected, and the administration of sugammadex resulted in swift recovery of hemodynamics. The basophil activation test revealed a positive reaction to rocuronium. CONCLUSION: The possibility of rocuronium-induced anaphylaxis should be considered when the circulatory collapse coincides with rocuronium administration, even though cutaneous manifestation is absent. Sugammadex can be a treatment option in such atypical cases. Springer Berlin Heidelberg 2020-12-07 /pmc/articles/PMC7721765/ /pubmed/33289045 http://dx.doi.org/10.1186/s40981-020-00402-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Case Report
Takise, Yoshiaki
Kato, Jungo
Suhara, Tomohiro
Yamada, Takashige
Funakoshi, Takeru
Takahashi, Hayato
Amagai, Masayuki
Morisaki, Hiroshi
Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
title Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
title_full Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
title_fullStr Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
title_full_unstemmed Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
title_short Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
title_sort life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721765/
https://www.ncbi.nlm.nih.gov/pubmed/33289045
http://dx.doi.org/10.1186/s40981-020-00402-y
work_keys_str_mv AT takiseyoshiaki lifethreateningrocuroniuminducedanaphylacticshockwithoutcutaneousmanifestationssuccessfullyreversedwithsugammadexacasereport
AT katojungo lifethreateningrocuroniuminducedanaphylacticshockwithoutcutaneousmanifestationssuccessfullyreversedwithsugammadexacasereport
AT suharatomohiro lifethreateningrocuroniuminducedanaphylacticshockwithoutcutaneousmanifestationssuccessfullyreversedwithsugammadexacasereport
AT yamadatakashige lifethreateningrocuroniuminducedanaphylacticshockwithoutcutaneousmanifestationssuccessfullyreversedwithsugammadexacasereport
AT funakoshitakeru lifethreateningrocuroniuminducedanaphylacticshockwithoutcutaneousmanifestationssuccessfullyreversedwithsugammadexacasereport
AT takahashihayato lifethreateningrocuroniuminducedanaphylacticshockwithoutcutaneousmanifestationssuccessfullyreversedwithsugammadexacasereport
AT amagaimasayuki lifethreateningrocuroniuminducedanaphylacticshockwithoutcutaneousmanifestationssuccessfullyreversedwithsugammadexacasereport
AT morisakihiroshi lifethreateningrocuroniuminducedanaphylacticshockwithoutcutaneousmanifestationssuccessfullyreversedwithsugammadexacasereport